De Puy hips recall

 

07 I 04 I 11

Bookmark and Share

DePuy ASR hip replacement implants have been in clinical use in the UK since 2003. However, the manufacturer has now determined that the revision rate for all devices, in the ASR systems, at five years is higher than expected across the entire size range.  This discovery has led to De Puy now  recalling all ASR system hip replacement implants. The recall includes those involved in both the total hip replacement surgery and hip resurfacing.

Hugh James are representing patients who have been part of this recall and have either had their De Puy implants replaced or are being investigated to determine if they will need to.

De Puy’s recall includes funding the costs of investigation and treatment and patient’s expenses. However, in conjunction with a handful of other law firms across Britain, Hugh James has been negotiating for the payment of compensation for all of the effects of having these implants treatments.

This compensation may include the payment of loss of earnings or nursing care. In addition, the claim will include an independent review of the long term effects of the implant and its revision.


 

Further information

The DePuy ASR system consists of:

  • ASR acetabular cups for hip resurfacing arthroplasty or total hip replacement
  • ASR surface replacement heads for hip resurfacing arthroplasty
  • ASR XL femoral heads for total hip replacement

 

The MHRA published a recall notice on the 7 September 2010. To view this notice please visit the MHRA website

 

The British Hip Society held its annual conference from 2nd – 4th March and published a paper on the subject of large diameter metal on metal bearing total hip replacements, including the De Puy ASR devices.

The presented results show a higher than anticipated early failure rate. These range from a 21% revision rate at four years (potentially rising to 35% if all currently known painful implants progress to revision) to 49% at 6 years for the ASR XL device. Other devices have a revision or impending revision rate of 12 – 15 % at 5 years.

 

Patients who have these implants but have not yet been contacted by the clinics or hospitals who fitted them should contact them without delay. The recall does not apply to any other De Puy products but patients who have any form of metal on metal hip implants should contact their GP for advice

Contact

Mark Harvey colourMark Harvey

Partner, Head of the Claimant Division

Head of Harmful Products and Overseas Accidents Team

 

E mark.harvey@hughjames.com

T 029 2039 1174

Design by Brand 68 | Development by Fusionworkshop | SEO by Pinnacle Internet Marketing